ReviewGalen medical journal2024
A Narrative Review on Biologic Joint Therapy in Chronic Bilateral Mandibular Luxation : Biologic Joint Therapy in Chronic Bilateral Mandibular Luxation.
Review in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Temporomandibular joint (TMJ) luxation, or dislocation, is a relatively infrequent but highly consequential condition that requires prompt medical attention. This narrative review strives to offer a thorough summary of TMJ luxation treatment modalities, with a focus on recent advancements in biological treatments. Materials and Methods: A narrative review was conducted by synthesizing data from various sources, including systematic reviews, meta-analyses, and clinical trials. The review covers studies published up to 2024. Results: Various surgical techniques, such as eminectomy, midline mandibulotomy, and extended prosthetic total TMJ reconstruction (eTMJR), have been used to treat chronic TMJ dislocation. Platelet-rich plasma (PRP) and hyaluronic acid (HA) have shown promise in treating TMJ disorders. PRP can promote healing and reduce inflammation, while HA improves mandibular mobility and reduces pain. A combination of HA and PRP has been found to be particularly effective in treating TMJ disorders. Autologous blood injection (ABI) has been shown to be effective in reducing the recurrence of dislocation and improving patient outcomes, with fewer side effects compared to other treatments. Conclusion: TMJ luxation is a multifactorial condition that requires prompt and appropriate management to prevent long-term complications. While various surgical techniques are available, biological treatments such as PRP, HA, and ABI have shown promising results, particularly in reducing pain and improving joint function. Further research, including randomized controlled trials, is required to ascertain the most efficacious therapy modalities and to refine clinical guidelines for the management of TMJ luxation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.